iShares Biotechnology ETF(IBB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IBB iShares Biotechnology ETF

Market Closed 11-13 16:00:00 EST

212.50

-0.93

-0.44%

盘后211.69

-0.81-0.38%

19:56 EST

High213.50	Low210.48	Vol1.50M
Open213.24	D1 Closing213.43	Amplitude1.41%
Mkt Cap11.10B	Tradable Cap11.10B	Total Shares52.25M
T/O319.04M	T/O Rate2.88%	Tradable Shares52.25M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":212.5,"timestamp":1794603600000,"preClose":213.43,"halted":0,"volume":1503352,"hourTrading":{"tag":"盘后","latestPrice":211.69,"preClose":212.5,"latestTime":"19:56 EST","volume":4675,"amount":987901.7271,"timestamp":1794617810161,"change":-0.81,"changeRate":-0.003812,"amplitude":0.011294},"delay":0,"changeRate":-0.004357400552874511,"floatShares":52250000,"shares":52250000,"eps":6.311863,"marketStatus":"Market Closed","change":-0.93,"latestTime":"11-13 16:00:00 EST","open":213.235,"high":213.4957,"low":210.48,"amount":319039602.51816,"amplitude":0.01413,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":213.43,"sharesOutstanding":49450000,"nav":212.48669,"aum":11059932214.5,"dividendRate":0.001607,"bidAskSpread":0.00046,"preHourTrading":{"tag":"盘前","latestPrice":213.47,"preClose":213.43,"latestTime":"09:29 EST","volume":2031,"amount":433829.58183,"timestamp":1794580199999,"change":0.04,"changeRate":0.000187,"amplitude":0.021646},"postHourTrading":{"tag":"盘后","latestPrice":211.69,"preClose":212.5,"latestTime":"19:56 EST","volume":4675,"amount":987901.7271,"timestamp":1794617810161,"change":-0.81,"changeRate":-0.003812,"amplitude":0.011294},"volumeRatio":0.7345822704993672,"optionData":{"bulkOrders":[{"symbol":"IBB","call":false,"expireDate":1805428800000,"strike":"200.0","timestamp":1794590931279,"price":7.39,"volume":3550,"amount":2623450,"type":"+"}]},"impliedVol":0.2819,"impliedVolPercentile":0.9124},"requestUrl":"/m/hq/s/IBB/wiki","defaultTab":"wiki","newsList":[{"id":"2683633055","title":"Vertex (VERX) Is Back In Focus, But What Is Driving The Attention?","url":"https://stock-news.laohu8.com/highlight/detail?id=2683633055","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683633055?lang=en_us&edition=fundamental","pubTime":"2026-11-14 19:23","pubTimestamp":1794655382,"startTime":"0","endTime":"0","summary":"AAl BentleyNovember 14, 2026","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/8041000-choice1-card/1788934448378","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/8041000-choice1-card/1788934448378"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-verx/vertex/news/vertex-verx-is-back-in-focus-but-what-is-driving-the-attenti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-verx/vertex/news/vertex-verx-is-back-in-focus-but-what-is-driving-the-attenti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU1815336091.USD","LU0417517546.SGD","BK4532","BBH","LU2417539215.USD","IE00BJJMRZ35.SGD","VERX","PBE","LU0234570918.USD","SG9999001176.USD","BK4588","LU2468319806.SGD","BK4139","IE0002141913.USD","BIB","SG9999013999.USD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","VRTX","SG9999001176.SGD","LU1093756168.USD","IE00B19Z9Z06.USD","LU0079474960.USD","IDNA","LU2362541273.HKD","GNMX","LU1674673691.USD","LU2456880835.USD","IE0002270589.USD","IE00B4R5TH58.HKD","LU0432979614.USD","LU0889565916.HKD","LU1585245621.USD","BK4533","TBXU","IBB","LU0289739699.SGD","LU0109394709.USD","IE00B2B36J28.USD","IBBQ","LU2089984988.USD","LU0320765992.SGD","LU2236285917.USD","LU2237438978.USD","LU0566484027.USD","LU1559883803.SGD","LU1093756325.SGD","LU1778281490.HKD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683681984","title":"Gilead Expects HIV Revenue to Grow About 12% in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2683681984","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683681984?lang=en_us&edition=fundamental","pubTime":"2026-11-14 08:44","pubTimestamp":1794617055,"startTime":"0","endTime":"0","summary":"Gilead Expects HIV Revenue to Grow About 12% in 2026Gilead expects fiscal 2026 HIV revenue growth of about 12%, with Yeztugo revenue forecast at approximately $1 billion.Third-quarter HIV sales rose 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261114:nNDL3tJvwL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","IE00BKVL7J92.USD","BK4532","LU1037948897.HKD","IE00B3T34201.USD","LU1585245621.USD","BMED","LU1571399168.USD","LU1778281490.HKD","SG9999015986.USD","TBXU","LU1057294990.SGD","IE00B7SZLL34.SGD","BK4550","LU2065171311.SGD","BK4566","LU2357627491.SGD","LU0889565916.HKD","LU1839511570.USD","LU0320765992.SGD","IBBQ","LU0114720955.EUR","BK4588","LU0965508806.USD","LU1236620834.HKD","LU2112291526.USD","BBH","LU0234570918.USD","LU1037948541.HKD","LU0058720904.USD","SG9999015945.SGD","LU0289739699.SGD","MEDI","LU0859254822.USD","BK4583","BK4578","LU1430594728.SGD","LU1236620750.USD","SG9999015952.SGD","LU1934455277.USD","LU2324357040.USD","LU0965509283.SGD","BIB","TMED","LU0861579265.USD","GILD","LU0122379950.USD","LU0109394709.USD","BK4585","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683689144","title":"AstraZeneca announces FDA approval of imfinzi/EV combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2683689144","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683689144?lang=en_us&edition=fundamental","pubTime":"2026-11-14 07:45","pubTimestamp":1794613519,"startTime":"0","endTime":"0","summary":"AstraZeneca’s (AZN) imfinzi in combination with enfortumab vedotin-ejfv as neoadjuvant treatment, followed by imfinzi monotherapy as adjuvant treat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-announces-fda-approval-of-imfinzi-ev-combination-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-announces-fda-approval-of-imfinzi-ev-combination-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","LU2237443895.HKD","MEDI","IEIH","LU0289739699.SGD","IE00B3T34201.USD","MRNX","LABU","LU2236285917.USD","LU2089984988.USD","LU0320765992.SGD","XLVX","LU0029864427.USD","FRTY","LU0310800379.SGD","IBB","PSCH","PINK","LU2237443622.USD","BMED","AZN","IYH","SYNB","BK4585","BBP","CARD","LU1829250122.USD","LU2237443382.USD","TBXU","AZNH","LU2456880835.USD","RSPH","BK4568","NVIB","LU2468319806.SGD","MRNY","LU0708994859.HKD","LU2417539215.USD","TECB","LU1267930573.SGD","LU2462157665.USD","GNMX","LFSC","LU0889565916.HKD","LU0432979614.USD","GDOC","LU2237443978.SGD","LU2237443549.SGD","BK4007","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683858956","title":"Moderna Inc. Stock Slips 3.4%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2683858956","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683858956?lang=en_us&edition=fundamental","pubTime":"2026-11-14 05:35","pubTimestamp":1794605700,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. shed 3.4% to $223.37 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 52,347.55 and the NASDAQ Composite Index falling 0.9% to 25,136.27.This was the stock's fourth consecutive day of losses.Moderna Inc. closed 20.5% short of its 52-week high of $280.80, which the company reached on November 9th.The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.8% to $285.75, Pfizer Inc. rose 0.2% to $28.89, and Gilead Sciences Inc. rose 0.08% to $168.08.Trading volume totaled 8.0 million, compared to the 50-day average of 15.9 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU1674673428.USD","GNOM","LU2089984988.USD","SG9999015952.SGD","BK4550","BMED","LU1236620750.USD","LU2065171311.SGD","LU0109394709.USD","IE00B7SZLL34.SGD","WDNA","LU1061106388.HKD","BK4501","IBB","LU2065169927.USD","LGHT","LU1934455277.USD","LU2087621335.USD","MRNA","BIB","LU0965509010.AUD","LU0859254822.USD","TMED","MRNY","LU0289739699.SGD","LU0889565916.HKD","MRNX","IDNA","GILD","BK4551","LU2065171402.SGD","TBXU","LU0965509283.SGD","LU1934455863.HKD","LU1037948541.HKD","LU1430594728.SGD","SG9999015978.USD","LU2324357040.USD","IE00B19Z3B42.SGD","LU1585245621.USD","LU2065170008.USD","BK4532","IBBQ","LU0122379950.USD","BBH","BK4566","BK4548","LU1934455194.USD","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683881726","title":"Sector Update: Healthcare Stocks Rise Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2683881726","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683881726?lang=en_us&edition=fundamental","pubTime":"2026-11-14 04:31","pubTimestamp":1794601915,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher late Friday afternoon, with the NYSE Healthcare Index rising 0.8% and the State Street Health Care Select Sector SPDR ETF  adding 0.6%.The iShares Biotechnology ETF  was easing 0.2%.In corporate news, AstraZeneca  has eliminated around 600 positions in its respiratory and immunology commercial teams in the US as part of its three-year program to cut costs and reallocate resources to developing new drugs, Bloomberg reported. AstraZeneca shares were up 0.3%.Windward Bio  shares surged 72% in their Nasdaq debut on Friday after the clinical-stage biotechnology company sold 10.3 million shares at $17 apiece in its initial public offering.NeuroPace  shares fell 44% after it reduced its full-year revenue outlook as Q3 sales lagged market expectations, according to results posted late Thursday.SBC Medical Group  shares jumped 31% after it said it has made a minority equity investment in Taiwan-based NeuroBrain Dynamics and agreed to jointly develop six medical AI ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","NPCE","SBC","LABU","LU0320765992.SGD","BK4585","LU1267930573.SGD","TNDM","LU0432979614.USD","LU0058720904.USD","LU0289739699.SGD","LU0310800379.SGD","XBI","LU1829250122.USD","LU0708994859.HKD","BK4539","LU2417539215.USD","LU2462157665.USD","XLV","BK4082","LU2237443382.USD","IE00B3T34201.USD","LU2236285917.USD","LU2089984988.USD","IBB","LU0109394709.USD","LU0128525929.USD","LU0889565916.HKD","WWB","LU0029874061.USD","LU2237443622.USD","LU2237443895.HKD","LU2237443549.SGD","BK4137","LU2468319806.SGD","LU2456880835.USD","LU2237443978.SGD","BK4588","BK4568","HCSG","LU0128526141.USD","BK4581","LU0029864427.USD","LU2237443465.HKD","AZN","AZNH","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683337688","title":"AstraZeneca’s Alexion receives FDA approval for Klygefa","url":"https://stock-news.laohu8.com/highlight/detail?id=2683337688","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683337688?lang=en_us&edition=fundamental","pubTime":"2026-11-14 03:25","pubTimestamp":1794597924,"startTime":"0","endTime":"0","summary":"Klygefa is indicated for the treatment of generalized myasthenia gravis in adult patients who are antiacetylcholine receptor antibody positive, acc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazenecas-alexion-receives-fda-approval-for-klygefa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazenecas-alexion-receives-fda-approval-for-klygefa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","BK4585","TBXU","BBP","MRNX","XLVX","PINK","SYNB","LABU","IBB","IEIH","NVIB","IDNA","TECB","RSPH","FRTY","BMED","LFSC","IYH","GNMX","BK4588","MEDI","GDOC","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683072915","title":"Argenx Price Target Cut to $1130.00/Share from $1190.00 by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2683072915","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683072915?lang=en_us&edition=fundamental","pubTime":"2026-11-14 02:03","pubTimestamp":1794592980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARGX/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4505","LU0390134368.USD","IE0002141913.USD","LU0889565916.HKD","LU0109394709.USD","LU1983260115.SGD","FMED","BK4585","BK4139","IBB","TBXU","IE0034235188.USD","LU2324357040.USD","IE00BFTCPJ56.SGD","BK4588","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","ARGX","IE00B4R5TH58.HKD","LU0823416689.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683506286","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Producer Inflation Trails Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2683506286","media":"MT Newswires Live","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683506286?lang=en_us&edition=fundamental","pubTime":"2026-11-13 22:13","pubTimestamp":1794579196,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) was 0.2% higher in Friday's premarket activity as producer-price inflatio","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STLA","FAZ","SPY.AU","IBB","ETH","IYE","QXO","XLE","FDN","BITO","IGM","SLS.AU","NGHT","VDC","VHT.AU","XLI","QQQ",".DJI","RTH.AU","XLV","EETH","KEP","IYH","OOQB","VIS","RTH","SMFG","SLV","XLP","XLY","NVDA","IYJ","EQR","USO","STT","XLK",".IXIC","UNG","XRT","IYW","GLD","XLF","FAS","BETH","SLS","SOXX","SPY","XSD","IYK","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683508306","title":"Vir Biotechnology Tumbles on $150 Mln Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2683508306","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683508306?lang=en_us&edition=fundamental","pubTime":"2026-11-13 20:32","pubTimestamp":1794573143,"startTime":"0","endTime":"0","summary":"BUZZ-Vir Biotechnology tumbles on $150 mln stock sale** Vir Biotechnology'sVIR.Oshares tumble 15.7% to $10.22 before the bell after $150 mln overnight follow-on priced** VIR late Thurs announced 15 mln shares at $10, a 17.5% discount to last sale** Leerink, Morgan Stanley and Evercore bookrunners** On Mon, VIR's stock jumped nearly 12% to close at $13.64 after co said its chronic hepatitis delta  therapy met primary endpoint in Phase 3 trial** Last month, coinked up to $1.9 bln licensing dealwith GileadGILD.Ofor three candidates targeting selected solid tumor-associated antigens** VIR intends to use net offering proceeds to fund pre-commercial activities for its CHD program, investments in its T-cell engager  oncology platform, among other purposes, per the prospectus** San Francisco, California-based VIR has ~171.3 mln shares outstanding; through Thurs, stock doubled YTD** All 9 analysts are bullish on the stock and their median PT is $23, per LSEG data","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261113:nL6N46U0RY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU0971096721.USD","LU2111349929.HKD","LU2023251221.USD","LU1674673428.USD","BIB","IE00B19Z3B42.SGD","LU1244550494.USD","LU0106261372.USD","LU0158827781.USD","LU1037948541.HKD","EVR","IE00B775SV38.USD","IAI","LU0210528500.USD","VIR","LU1057294990.SGD","LU0122379950.USD","LU1061106388.HKD","LU2264538146.SGD","BMED","LU2089283258.USD","TBXU","IBB","LU2271345857.HKD","BBH","LU0234570918.USD","LU2089284900.SGD","LU1548497426.USD","IE00B3S45H60.SGD","LU1674673691.USD","LU2065170008.USD","LU1720051108.HKD","LU1732800096.USD","LU2357627491.SGD","LU2065171402.SGD","LU2089984988.USD","TMED","LU1066053197.SGD","LU1430594728.SGD","LU0390134368.USD","LU1778281490.HKD","GILD","LU2133065610.SGD","BK4550","LU0795875169.SGD","KBWB","MEDI","IBBQ","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683457264","title":"EMA's CHMP Recommends Extensions of Indication for Bexsero & Talzenna","url":"https://stock-news.laohu8.com/highlight/detail?id=2683457264","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683457264?lang=en_us&edition=fundamental","pubTime":"2026-11-13 19:16","pubTimestamp":1794568562,"startTime":"0","endTime":"0","summary":"BRIEF-EMA's CHMP Recommends Extensions Of Indication For Bexsero & TalzennaNov 13 -EMA's CHMP:EMA'S CHMP: RECOMMENDED EXTENDING USE OF GAZYVARO  TO TREAT ADULTS WITH MODERATE-TO-SEVERE ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUSEMA'S CHMP: RECOMMENDS GRANTING MARKETING AUTHORISATION FOR BAXFENDYEMA'S CHMP: RECOMMENDED EXTENSIONS OF INDICATION FOR BEXSERO, COSENTYX, DOVATO, ENFLONSIA, STEGLATRO, SUNLENCA, TALZENNA, TIVICAY, WELIREGEMA'S CHMP: RECOMMENDS EXTENSION OF THERAPEUTIC INDICATION FOR TALZENNAEMA'S CHMP: RECOMMENDS EXTENSION OF THERAPEUTIC INDICATION FOR STEGLATROEMA'S CHMP: ADOPTED DHPC ABOUT POTENTIAL EFFECT OF MOUNJARO  ON RELIABILITY OF ORAL CONTRACEPTIVESEMA'S CHMP: DHPC REMINDS HEALTHCARE PROFESSIONALS THAT CONTRACEPTION IS RECOMMENDED FOR WOMEN WHO CAN BECOME PREGNANT & USING MOUNJARO","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261113:nFWN46U0XW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0133085943.USD","XLV","IE00B19Z3B42.SGD","LU2063271972.USD","SG9999015341.SGD","LLYX","TRUH","BK4516","LU1989772923.USD","LU0057025933.USD","IYH","LU0079474960.USD","IE00BBT3K403.USD","BK4588","LU0109394709.USD","IE0009355771.USD","LU0234572021.USD","SG9999013999.USD","IE0004445239.USD","LU2552382058.USD","LU1201861249.SGD","LU1917777945.USD","LU0208291251.USD","LU1778281490.HKD","LU2237443549.SGD","LU1941712264.USD","IE00B1BXHZ80.USD","IE00BKDWB100.SGD","IHE","LU0345770308.USD","IE00BKVL7J92.USD","LU2213496289.HKD","BK4534","LU2236285917.USD","LU2237443895.HKD","LU2456880835.USD","LU2357305700.SGD","VHT","GILD","IE00B7KXQ091.USD","LU2360106947.USD","LU1868837300.USD","LU2237443978.SGD","LU2065169927.USD","LU0456855351.SGD","MEDX","MEDI","LU0472753341.HKD","LU2756315664.SGD","LU1267930573.SGD","LU1868836591.USD","LU1868836757.USD","LU0234570918.USD","SG9999003800.SGD","LU0672654240.SGD","LU2168564065.EUR","TBXU","LLII","LU0203201768.USD","LU2324357040.USD","SGXZ81514606.USD","IE0002270589.USD","LU2750360641.GBP","IE000M9KFDE8.USD","LU1093756325.SGD","LU2468319806.SGD","LU0661504455.SGD","LU2211817866.USD","LU2896262040.SGD","LU0859254822.USD","THNR","IE00B3T34201.USD","LU1066051225.USD","JDOC","IE00BJLML261.HKD","LU1323610961.USD","IE00B775H168.HKD","LU2265009873.SGD","LU1066051498.USD","LU1691799644.USD","LU1037948541.HKD","LU2756315318.SGD","LU1116320737.USD","LU1061106388.HKD","BK4007","LU0353189763.USD","LU2471134879.HKD","SGXZ99366536.SGD","LU1804176565.USD","LU0225771236.USD","LU2106854487.HKD","LU0203202063.USD","LU1923622614.USD","LU2065171311.SGD","LU2417539215.USD","GDOC","LU0353189680.USD","WDNA","LU0170899867.USD","LU0058720904.USD","LU2125909247.SGD","SG9999014559.SGD","LU0882574055.USD","LU0158827948.USD","LU0689626769.HKD","IE00B4JS1V06.HKD","LU1236620834.HKD","BK4532","LU1127390331.HKD","LU2361044949.HKD","SG9999001176.USD","LU0943347566.SGD","LU2471134796.USD","SG9999011175.SGD","LU1929549753.HKD","BK4578","LU1868837136.USD","LU0417517546.SGD","LU2264538146.SGD","LU0708995401.HKD","LU0689472784.USD","LU1551013342.USD","LU2211815571.USD","PAWZ","BK4533","LU0949170772.SGD","LU2491050071.SGD","IE00BJJMRX11.SGD","IE00BKPKM429.USD","LU2023250843.SGD","LU0070302665.USD","LU2491050154.USD","LU0069063385.USD","LU2361044865.SGD","SG9999014906.USD","IE00BFSS8Q28.SGD","LU0198837287.USD","LU0289961442.SGD","LU1145028129.USD","LU2746668461.USD","LU1720051108.HKD","LU0203347892.USD","CURE","IXJ","LU1839511570.USD","LU1003077747.HKD","SG9999014567.USD","LU0128525929.USD","LU1035775433.USD","LU0011850046.USD","LU0965509283.SGD","BIB","LU1585245621.USD","LU2462157665.USD","OZEM","LU2357627491.SGD","PPH","LU1989772840.SGD","SG9999015358.SGD","LU0889565916.HKD","LU1023059063.AUD","GSK.UK","LU0006306889.USD","CANC","LU1989771016.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","LU0124676726.USD","LU2108987350.USD","LU2087621335.USD","HRTS","IE00B1XK9C88.USD","LU0965509101.SGD","LU2552382215.SGD","PFE","LU0471298694.HKD","LLY","SG9999014914.USD","LU1236620750.USD","LU2087625088.SGD","LU2237443622.USD","IE00BFTCPJ56.SGD","LU0238689110.USD","LU0882574139.USD","BK4568","LU1883839398.USD","LU0210536198.USD","FHLC","LU0321505868.SGD","LU2237438978.USD","LU0861579265.USD","LU0211331839.USD","LU0162691827.USD","LU0823434740.USD","IE00B7SZLL34.SGD","LU0820561909.HKD","LU1032466523.USD","LU2433249047.HKD","LU0345770993.USD","LU1057294990.SGD","LU0130517989.USD","LLYZ","LU0320765059.SGD","SGXZ51526630.SGD","LU2168564222.USD","LU0061475181.USD","LU2023251221.USD","LU2746668974.SGD","LU1162221912.USD","LU0174119429.USD","LU0648001328.SGD","LU2461242641.AUD","LU0265550946.USD","LU0096364046.USD","LU2065170008.USD","LU1814569148.SGD","LU0323591593.USD","LU0466842654.USD","LU1712237335.SGD","IE00BJT1NW94.SGD","LU1829250122.USD","LU2750360997.AUD","BK4581","LU0256863902.USD","BK4559","ELIL","LU1974910355.USD","SG9999014575.USD","LU0320765489.SGD","LU1983299246.USD","LU0109391861.USD","LU1153585028.USD","LU1551013425.SGD","LU2491049909.HKD","LU1066053197.SGD","BK4585","LU0820561818.USD","SG9999018857.SGD","PJP","IBB","LU1280957306.USD","LU0320765646.SGD","LU1035773651.USD","LU1894683264.USD","LU0256863811.USD","LU2462591350.SGD","SGXZ31699556.SGD","LU0098860793.USD","LU1571399168.USD","LU0640476718.USD","LU0122379950.USD","LU1291159041.SGD","LU2168564495.EUR","LU0072461881.USD","LU0097036916.USD","BMED","LU1093756168.USD","SG9999017495.SGD","LU1116320901.HKD","IE00BJJMRY28.SGD","LU1267930730.SGD","LU0029864427.USD","BK4550","RXL","LU0225284248.USD","LU2237443465.HKD","LU2125909593.SGD","LU2023250330.USD","LU1894683348.USD","LU0354030511.USD","LU2602419157.SGD","LU1037948897.HKD","IE0002141913.USD","LU0306807586.USD","LU2125154935.USD","LU2125154778.USD","IE00BK4W5L77.USD","LU1064131342.USD","LU1069347547.HKD","LU0823416689.USD","LU0106261372.USD","LU2023250504.SGD","BK4139","AZNH","LU1934455277.USD","LU0203345920.USD","IE0005OL40V9.USD","LU0553294199.USD","LU0158827781.USD","LU1548497426.USD","LU0310800379.SGD","IE00BWXC8680.SGD","IE00BZ1G4Q59.USD","LU0306806265.USD","LU1066051811.HKD","LU2471134523.USD","LU0787776722.HKD","MRK","LU0820562030.AUD","LU2168564149.EUR","IE00BFSS7M15.SGD","LU2361045086.USD","SG9999015945.SGD","IE00BK4W5M84.HKD","LU0786609619.USD","LU0130102774.USD","LU1720051017.SGD","LU1868836914.USD","LU1629891620.HKD","LU0985481810.HKD","LU0471298777.SGD","LU1934455194.USD","LU2237443382.USD","LU2271345857.HKD","LU0823434583.USD","LU0965509010.AUD","LU2360032135.SGD","BK4566","SG9999018865.SGD","BK4592","LU2065171402.SGD","LU1366192091.USD","LU1988902786.USD","BK4583","LU2111349929.HKD","IE00B2B36J28.USD","IBBQ","LU0708994859.HKD","ILDR","LU0477156953.USD","LU0432979614.USD","LU1674673691.USD","IE0004445015.USD","LU2596442595.SGD","LU0266013472.USD","SG9999014880.SGD","SG9999002232.USD","LU0942090050.USD","LU2112291526.USD","SG9999001176.SGD","AZN","LU2089283258.USD","LU0511384066.AUD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0985320562.USD","LU0965508806.USD","BK4599","LU1979441026.SGD","LU1934455863.HKD","SG9999015978.USD","LU2471134952.CNY","GSK","LU0354030438.USD","ELIS","LU0868494708.USD","LU0289739343.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0964807845.USD","MHIP","FTXH","IE00BLSP4452.SGD","AGNG","SG9999001440.SGD","LU0321505439.SGD","LU0316494557.USD","LU2089284900.SGD","LU0225283273.USD","LU1699723380.USD","LU1232071149.USD","LU1430594728.SGD","SG9999015952.SGD","LU0868494617.USD","IE00BLSP4239.USD","LU1623119135.USD","LU0683600562.USD","LU2552382132.HKD","LU0738911758.USD","LU0094547139.USD","LU0385154629.USD","GB00BDT5M118.USD","LU0980610538.SGD","LU0545039389.USD","BBH","LU2168563687.JPY","IE00BN8TJ469.HKD","GSKH","LU2089984988.USD","SG9999014898.SGD","IE00BN29S564.USD","LU1069344957.HKD","TMED","LU0289739699.SGD","LU2028103732.USD","SG9999014542.SGD","SG9999015986.USD","LU1674673428.USD","LU0265550359.USD","LU1941712348.USD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","SG9999002224.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683604576","title":"Missed Regeneron Pharmaceuticals' Rally? Here Is What Holders Saw","url":"https://stock-news.laohu8.com/highlight/detail?id=2683604576","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683604576?lang=en_us&edition=fundamental","pubTime":"2026-11-13 17:20","pubTimestamp":1794561602,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 13, 2026","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/company-cover/33715-card/1789122008118","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/company-cover/33715-card/1789122008118"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/missed-regeneron-pharmaceuticals-rally-here-is-what-holders","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/missed-regeneron-pharmaceuticals-rally-here-is-what-holders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TBXU","LU1974910355.USD","LU2362541273.HKD","LU0823434583.USD","LU2023250504.SGD","LU2468319806.SGD","LU2237438978.USD","LU2106854487.HKD","REGN","LU0058720904.USD","LU0320765992.SGD","BBH","LU2324357040.USD","LU0109394709.USD","BK4139","LU0889565916.HKD","LU0114720955.EUR","LU2362541513.USD","LU1917777945.USD","LU0823416689.USD","LU0053666078.USD","LU2362540622.SGD","BK4588","LU2089984988.USD","IBB","IBBQ","LU0289739699.SGD","LU0823434740.USD","BK4585","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185599265","title":"Insilico Medicine (03696) Forms AI Drug Development Strategic Partnership with Luoxin Pharmaceutical (002793.SZ), Focusing on Innovative Therapies for Chronic Diseases Including Digestive and Metabolic Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=1185599265","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185599265?lang=en_us&edition=fundamental","pubTime":"2026-11-13 16:36","pubTimestamp":1794558985,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) announced that its wholly-owned subsidiary, Insilico Medicine Technology (Shanghai) Co., Ltd., has recently signed a strategic cooperation agreement with Luoxin...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK0239","BK0132","LFSC","QTOC","BIOY","VTHR","PBE","IBB","WRND","XLVI","SBIO","GSKH","BK0001","BBP","CHAT","BK1141","002793","BK4585","APXH","BK1191","BK0201","AIPO","01477","BK4588","AGIX","ARTY","BK1574","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683527336","title":"Gilead (GILD) Stock May Be 44% Undervalued After Lenacapavir News","url":"https://stock-news.laohu8.com/highlight/detail?id=2683527336","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683527336?lang=en_us&edition=fundamental","pubTime":"2026-11-13 15:20","pubTimestamp":1794554412,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 13, 2026","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/company-cover/29002-card/1789028982321","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/company-cover/29002-card/1789028982321"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-may-be-44-undervalued-after-lenacapavir-ne","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-may-be-44-undervalued-after-lenacapavir-ne","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065171311.SGD","LU0109394709.USD","LU0889565916.HKD","LU2324357040.USD","IBBQ","IE00BSNM7G36.USD","LU0965508806.USD","DCF","BK4139","LU1674673428.USD","LU2112291526.USD","BK4585","TBXU","LU0859254822.USD","LU2087621335.USD","LU1037948541.HKD","BBH","SG9999015978.USD","LU1023059063.AUD","BK4550","LU0965509010.AUD","SPHQ","BK4532","LU1236620834.HKD","BIB","IBB","LU2357627491.SGD","BK4583","TMED","BK4578","BMED","GILD","LU0965509283.SGD","LU1066051498.USD","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU1585245621.USD","LU0058720904.USD","LU0861579265.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU1571399168.USD","LU1430594728.SGD","BK4588","LU1674673691.USD","LU1934455194.USD","MEDI","LU2468319806.SGD","LU1057294990.SGD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166903090","title":"Can Moderna’s Cancer Vaccine Partnership With Merck Unlock New Growth?","url":"https://stock-news.laohu8.com/highlight/detail?id=1166903090","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166903090?lang=en_us&edition=fundamental","pubTime":"2026-11-13 09:56","pubTimestamp":1794534975,"startTime":"0","endTime":"0","summary":"","market":"fut","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/5475.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/5475.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Can Moderna’s Cancer Vaccine Partnership With Merck Unlock New Growth?","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","MRNX","MRK","XBI","IBB","MRNA","MRNY"],"isVideo":true,"video":{"duration":142,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/5475/render_5475_1794534327385.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/5475.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/5475/tts/voiceover_a7d48331a0967392ed939e8d.mp3","isAI":true},"gpt_icon":0},{"id":"2683541021","title":"Anterogen Reports AlloStem Japan Approval, Exports and QP스템주 Withdrawal","url":"https://stock-news.laohu8.com/highlight/detail?id=2683541021","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683541021?lang=en_us&edition=fundamental","pubTime":"2026-11-13 08:45","pubTimestamp":1794530755,"startTime":"0","endTime":"0","summary":"Anterogen Co., Ltd. ( ($KR:065660) ) has shared an announcement. Anterogen is a biotechnology company developing and producing adipose-derived stem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anterogen-reports-allostem-japan-approval-exports-and-qp-withdrawal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anterogen-reports-allostem-japan-approval-exports-and-qp-withdrawal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FWD","BBP","BK4585","IEIH","XT","LNGR","IBB","RSPH","SYNB","JDOC","AGNG","DARP","BK4588","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683545795","title":"Neurizon Extends Non-Dilutive R&D Facility to FY2027, Draws Approximately $3.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2683545795","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683545795?lang=en_us&edition=fundamental","pubTime":"2026-11-13 06:52","pubTimestamp":1794523927,"startTime":"0","endTime":"0","summary":"Pharmaust Limited ( ($AU:NUZ) ) has issued an update. Neurizon Therapeutics is a late-clinical-stage biotechnology company developing treatments fo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurizon-extends-non-dilutive-rd-facility-to-fy2027-draws-approximately-3-7-million?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurizon-extends-non-dilutive-rd-facility-to-fy2027-draws-approximately-3-7-million?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","SYNB","FHLC","FWD","IEIH","XT","AGNG","BBP","BK4588","LNGR","DARP","BK4585","RSPH","IBB","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683545305","title":"Press Release: Vertex Resource Group Ltd. Reports Third Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2683545305","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683545305?lang=en_us&edition=fundamental","pubTime":"2026-11-13 06:35","pubTimestamp":1794522900,"startTime":"0","endTime":"0","summary":"Profit margin %                          26 %       25 %       26 %      24 %. Adjusted EBITDA %                        17 %       14 %       16 %      12 %.  See \"Non-IFRS Financial Measures\"HIGHLIGHTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026-- Environmental Consulting net revenue increased 12.2% over prior period.-- G&A expenses decreased 11.7% year-over-year despite a $1.8 million. -- Adjusted EBITDA improved $1.7 million, or 23.5%, compared to 2025.-- Continued profitability with net income of $0.8 million, improving by. $1.9 million compared to 2025.HIGHLIGHTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026-- Environmental Consulting net revenue increased by 9.2% compared to 2025.-- G&A expenses reduced to 10.2% of net revenue, down $1.4 million from. -- Net income of $0.4 million, increasing by $7.2 million from a net loss in","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","BBH","SG9999001176.USD","LU0109394709.USD","IBB","LU1035775433.USD","LU0823416689.USD","SGXZ57979304.SGD","LU1815336091.USD","BK4139","LU0061475181.USD","LU1585245621.USD","LU1674673691.USD","LU2462157665.USD","LU2456880835.USD","IE00B2B36J28.USD","BK4585","PBE","LU0079474960.USD","LU1674673428.USD","IE0009355771.USD","LU2362541513.USD","IBBQ","BK4588","LU1559883803.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2237438978.USD","IE0002270589.USD","BIB","LU2417539215.USD","LU0058720904.USD","VRTX","IE00B19Z9P08.USD","LU2089984988.USD","GNMX","IE00B19Z9Z06.USD","LU2468319806.SGD","LU1093756325.SGD","IE00B19Z3581.USD","LU2362541273.HKD","VERX","IDNA","LU0320765992.SGD","LU0566484027.USD","TBXU","LU2236285917.USD","LU2362540622.SGD","BK4023","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683431535","title":"Regeneron's Baloncibart Reduces Standing Heart Rate Response in Phase 2 POTS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2683431535","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683431535?lang=en_us&edition=fundamental","pubTime":"2026-11-13 06:16","pubTimestamp":1794521779,"startTime":"0","endTime":"0","summary":"Regeneron's baloncibart reduces standing heart rate response in Phase 2 POTS trialRegeneron’s investigational baloncibart reduced excessive heart-rate increases upon standing in the Phase 2 PINNACLE t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nNDL8svd7V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","IE00BQXX3D17.EUR","LU0823416689.USD","BCDF","LU0823434740.USD","SG9999014005.SGD","IBBQ","LU2095319765.USD","IBB","LU0320765992.SGD","LU0314104364.USD","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","BBH","IE00BN0W2T93.GBP","LU2362541513.USD","REGN","BK4112","IE00BQXX3F31.USD","LU2362540622.SGD","IE00BQXX3C00.GBP","LU2089984988.USD","LU2210150020.SGD","LU0058720904.USD","LU0109394709.USD","SG9999014021.USD","LU2362541273.HKD","IE00BKPKM429.USD","LU1974910355.USD","LU0823434583.USD","LU2324357040.USD","NDAQ","LU0289739699.SGD","LU1917777945.USD","BK4139","SG9999014013.SGD","LU2106854487.HKD","LU0053666078.USD","LU0114720955.EUR","IE00BN0W2W23.USD","LU2237438978.USD","BK4588","SG9999014039.USD","IE00BGHQF748.EUR","TBXU","LU0882574055.USD","LU2468319806.SGD","IE00B64PRP62.GBP","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683543762","title":"Nanobiotix Discloses October 31 Voting Rights and Shares Outstanding","url":"https://stock-news.laohu8.com/highlight/detail?id=2683543762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683543762?lang=en_us&edition=fundamental","pubTime":"2026-11-13 06:15","pubTimestamp":1794521743,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($NBTX) ). Nanobiotix is a late-stage clinical biotechnology company developing physics-based therapeuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-discloses-october-31-voting-rights-and-shares-outstanding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-discloses-october-31-voting-rights-and-shares-outstanding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","SYNB","BK4585","LNGR","JDOC","DARP","BK4588","FWD","RSPH","IEIH","AGNG","XT","IBB","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683854821","title":"Regeneron Pharmaceuticals - Baloncibart 450 Mg Reduces Deltahr by -11.4 Bpm at Day 8, -7.4 Bpm at Day 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2683854821","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683854821?lang=en_us&edition=fundamental","pubTime":"2026-11-13 06:00","pubTimestamp":1794520800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nTUA9JT6DZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU2362540622.SGD","LU0320765992.SGD","LU1917777945.USD","LU2089984988.USD","LU2362541273.HKD","TBXU","BK4585","LU0889565916.HKD","LU1974910355.USD","LU0114720955.EUR","IBB","LU0823434740.USD","LU0053666078.USD","BBH","LU0058720904.USD","LU2023250504.SGD","LU0823434583.USD","LU0823416689.USD","LU2468319806.SGD","BK4588","LU0109394709.USD","BK4139","LU2106854487.HKD","LU2324357040.USD","IBBQ","LU2362541513.USD","REGN","LU0882574055.USD","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":0.0455},{"period":"3month","weight":0.0718},{"period":"6month","weight":0.2738},{"period":"1year","weight":0.3011},{"period":"ytd","weight":0.2591}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.722222,"avgChangeRate":0.019108},{"month":2,"riseRate":0.611111,"avgChangeRate":-0.001245},{"month":3,"riseRate":0.555556,"avgChangeRate":0.002788},{"month":4,"riseRate":0.5,"avgChangeRate":0.003638},{"month":5,"riseRate":0.611111,"avgChangeRate":0.009102},{"month":6,"riseRate":0.777778,"avgChangeRate":0.027534},{"month":7,"riseRate":0.722222,"avgChangeRate":0.03565},{"month":8,"riseRate":0.5,"avgChangeRate":0.006092},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.000493},{"month":10,"riseRate":0.421053,"avgChangeRate":-0.012027},{"month":11,"riseRate":0.789474,"avgChangeRate":0.037493},{"month":12,"riseRate":0.555556,"avgChangeRate":0.007272}],"exchange":"NASDAQ","name":"iShares Biotechnology ETF","nameEN":"iShares Biotechnology ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iShares Biotechnology ETF(IBB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest iShares Biotechnology ETF(IBB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"iShares Biotechnology ETF,IBB,iShares Biotechnology ETF股票,iShares Biotechnology ETF股票老虎,iShares Biotechnology ETF股票老虎国际,iShares Biotechnology ETF行情,iShares Biotechnology ETF股票行情,iShares Biotechnology ETF股价,iShares Biotechnology ETF股市,iShares Biotechnology ETF股票价格,iShares Biotechnology ETF股票交易,iShares Biotechnology ETF股票购买,iShares Biotechnology ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iShares Biotechnology ETF(IBB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest iShares Biotechnology ETF(IBB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}